Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...

The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...

They have announced a blockbuster matchup that is going to be scheduled for the 2026-27 season. At Madison Square Garden on November 8, Oats and the Crimson Tide will be taking on the St. John's ...

Alkem Laboratories Ltd.'s proposed copies of two extended-release Xeljanz dosages infringe a patent for Pfizer Inc.'s once-blockbuster arthritis drug, a federal lawsuit said. Pfizer alleged Alkem’s ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Johnson & Johnson JNJ and AbbVie ABBV are two major U.S. pharmaceutical companies with robust pipelines and global operations. Both companies have a strong presence in immunology, oncology and ...

Sequel Pharma Executes Agreement with CDMO for Drug Product Manufacturing Sequel is a U.S. based specialty pharma company with expertise in developing and commercializing niche drugs. It has committed ...